Nixon Peabody Trust CO Edwards Lifesciences Corp Transaction History

Nixon Peabody Trust CO

$1.18 Billion
Q3 2024

A detailed history of Nixon Peabody Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nixon Peabody Trust CO holds 7,647 shares of EW stock, worth $572,072. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,647

Previous 8,197 6.71%

Holding current value

$572,072

Previous $757,000 33.42%

% of portfolio

0.04%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$59.7 - $93.78 $32,835 - $51,579	-550 Reduced 6.71%	7,647 $504,000
Q2 2024 Jul 26, 2024	SELL	$84.3 - $94.31 $61,791 - $69,129	-733 Reduced 8.21%	8,197 $757,000
Q1 2024 May 07, 2024	BUY	$72.54 - $95.56 $35,907 - $47,302	495 Added 5.87%	8,930 $853,000
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $520,523 - $655,905	8,435 New	8,435 $643,000
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $795,899 - $1 Million	-7,806 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $830,324 - $1.02 Million	7,806 New	7,806 $1.01 Million
Q3 2021 Nov 04, 2021	SELL	$102.91 - $122.75 $199,027 - $237,398	-1,934 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$83.84 - $104.76 $162,146 - $202,605	1,934 New	1,934 $200,000
Q1 2021 Apr 26, 2021	SELL	$78.68 - $90.67 $175,141 - $201,831	-2,226 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $159,581 - $203,077	2,226 New	2,226 $203,000
Q1 2020 Apr 23, 2020	SELL	$52.41 - $81.0 $54,978 - $84,969	-1,049 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $2,509 - $2,873	-35 Reduced 3.23%	1,049 $245,000
Q3 2019 Nov 05, 2019	SELL	$61.55 - $75.43 $30,959 - $37,941	-503 Reduced 31.7%	1,084 $238,000
Q2 2019 Aug 01, 2019	SELL	$55.74 - $64.41 $24,804 - $28,662	-445 Reduced 21.9%	1,587 $293,000
Q1 2019 Apr 19, 2019	SELL	$47.89 - $64.05 $29,356 - $39,262	-613 Reduced 23.18%	2,032 $389,000
Q4 2018 Jan 23, 2019	SELL	$46.41 - $56.94 $12,994 - $15,943	-280 Reduced 9.57%	2,645 $405,000
Q3 2018 Oct 25, 2018	SELL	$45.7 - $58.03 $83,402 - $105,904	-1,825 Reduced 38.42%	2,925 $509,000
Q2 2018 Jul 30, 2018	SELL	$42.45 - $51.3 $76,622 - $92,596	-1,805 Reduced 27.54%	4,750 $691,000
Q1 2018 Apr 27, 2018	SELL	$37.19 - $47.45 $64,896 - $82,800	-1,745 Reduced 21.02%	6,555 $915,000
Q4 2017 Feb 05, 2018	SELL	$33.79 - $39.39 $6,251 - $7,287	-185 Reduced 2.18%	8,300 $936,000
Q3 2017 Nov 01, 2017	BUY	$36.29 - $38.83 $307,920 - $329,472	8,485	8,485 $927,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Nixon Peabody Trust CO with notifications on news.

Account

Nixon Peabody Trust CO Edwards Lifesciences Corp Transaction History